HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
Heartbeam, Inc. (BEAT)
Last heartbeam, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
gobio.com/investors/news-releases
Company Research
Source: Business Wire
HeartBeam Recently Received US Food and Drug Administration (FDA) Clearance for First-Ever Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia AssessmentPivotal Milestone Unlocks Multiple Key Initiatives in Company’s Growth Strategy SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that it will attend the JP Morgan 2026 Annual Healthcare Conference taking place January 12-15, 2026 at the Westin St. Francis Hotel in San Francisco, CA.HeartBeam Chief Executive Officer, Robert Eno, and Chief Financial Officer, Timothy Cruickshank, will be available January 12-14 for off-site meetings with investors and potential commercialization and co-development partners to discuss the recently announced US Food and Drug Administration (FDA) 510(k) clearance for the Company’s groundbreaking 12-lead electrocardiogram (ECG) synthesis software for the asse
Show less
Read more
Impact Snapshot
Event Time:
BEAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BEAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BEAT alerts
High impacting Heartbeam, Inc. news events
Weekly update
A roundup of the hottest topics
BEAT
News
- Credit-Card Sized Device Wins FDA Clearance for At-Home Heart Monitoring [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Top Midday Gainers [Yahoo! Finance]Yahoo! Finance
- HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia AssessmentBusiness Wire
- HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software ApplicationBusiness Wire
- HeartBeam (BEAT) Recognized as a Top Global Innovator in Portable ECG Technology [Yahoo! Finance]Yahoo! Finance
BEAT
Earnings
- 11/13/25 - Beat
BEAT
Sec Filings
- 12/22/25 - Form 4
- 12/19/25 - Form 4
- 11/21/25 - Form 8-K
- BEAT's page on the SEC website